Nattokinase
A fermented-soybean enzyme with real blood pressure trial data and a serious blood-thinner interaction
Nattokinase is an enzyme extracted from natto, a traditional Japanese food made from fermented soybeans. It has a long history of dietary use in Japan and has drawn supplement-world interest for its role in supporting the body's fibrinolytic system — the natural process that breaks down blood clots and helps maintain healthy circulation.
Unlike a lot of trending heart-health ingredients, nattokinase has actual randomized, placebo-controlled human trial data behind it, not just cell-culture or animal research. That real trial evidence is also exactly why it comes with a genuinely serious safety consideration: its effect on clotting pathways means it can interact meaningfully with blood thinners and antiplatelet medications, which is not a minor caution to skip past.
Blood Pressure Support
A randomized, placebo-controlled trial found an 8-week course produced a meaningful net reduction in both systolic and diastolic blood pressure.
Fibrinolytic (Clot-Breakdown) Support
Directly breaks down fibrin and activates additional pathways involved in the body's natural clot-dissolving process.
Cardiovascular Risk Marker Research
A meta-analysis of randomized controlled trials found nattokinase supplementation improved several measured cardiovascular risk factors.
Long Dietary History
Derived from natto, a food with a centuries-long history of regular dietary consumption in Japan.
- Never combine with warfarin, aspirin therapy, or other blood thinners without explicit medical approval
- Stop taking it at least 1-2 weeks before any scheduled surgery — confirm the exact timing with your surgeon
- Look for a product measured in FU (fibrinolytic units), the standard used in the clinical research
- Those with a bleeding disorder or upcoming procedures should get direct physician guidance before starting
A randomized, double-blind, placebo-controlled trial in 86 adults with systolic blood pressure between 130-159 mmHg found that 2,000 FU/day of nattokinase for 8 weeks produced a net reduction of 5.55 mmHg systolic and 2.84 mmHg diastolic blood pressure compared to placebo. A subsequent systematic review and meta-analysis of randomized controlled trials confirmed nattokinase supplementation significantly reduced both systolic and diastolic blood pressure across the pooled trial data.
How Nattokinase Compares
| Ingredient | Best For | Key Difference |
|---|---|---|
| Nattokinase | Blood Pressure, Circulation | Real RCT data, but requires blood-thinner caution |
| Hibiscus | Blood Pressure | Larger meta-analysis base, no comparable clotting interaction |
| CoQ10 | Heart & Energy Support | Different mechanism, commonly recommended alongside statins |
| Omega-3 | Cardiovascular Support | Broader evidence base, also carries a mild bleeding-risk caution at high doses |
These are the most common comparisons our customers ask about in-store.
1. Kim, J.Y., Gum, S.N., Paik, J.K., et al. (2008). Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension Research, 31(8), 1583–1588.
2. Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. Systematic Reviews / meta-analysis (2024).
All references are peer-reviewed studies or position stands from reputable organizations.
Related Ingredients
Get Your Free Supplement Guide
“50 Supplement Myths Debunked” PDF + weekly evidence-based tips. 100% free.
Get Your Free PDF →No spam, ever. Unsubscribe anytime.